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Abstract
Background: Invasive fusariosis (IF) is a rare but often fatal fungal infection in immunosuppressed patients. In 2007,
cases of IF above the expected epidemiologic baseline were detected in the hematology ward of a hospital in Rio
de Janeiro, Brazil. Possible sources of infection were investigated by performing environmental sampling and
patient isolate collection, followed by molecular typing. Isolates from dermatology patients with superficial fusariosis
were included in the study for comparison to molecular types found in the community.
Methods: Environmental sampling focused on water-related sources in and around the hematology ward. Initially,
we characterized 166 clinical and environmental isolates using the Fusarium translation elongation factor 1α (EF-1α)
genetic locus. Isolates included 68 collected from water-related sources in the hospital environment, 55 from 18
hematology patients, and 43 from the skin/nails of 40 outpatients seen at the hospital dermatology clinic.
Multi-locus sequence typing was performed on Fusarium solani species complex (FSSC) species 1 and 2 isolates to
investigate their relatedness further.
Results: Most of the hematology samples were FSSC species 2, with species type FSSC 2-d the most commonly
isolated from these patients. Most of the outpatient dermatology samples were also FSSC 2, with type 2-d again
predominating. In contrast, environmental isolates from water sources were mostly Fusarium oxysporum species
complex (FOSC) and those from air samples mostly Fusarium incarnatum-equiseti species complex (FIESC). A third of
the environmental samples were FSSC, with species types FSSC 1-a and FSSC 1-b predominating.
Conclusions: Fusarium isolate species types from hematology patient infections were highly similar to those
recovered from dermatology patients in the community. Four species types (FSSC 1-a, 1-b, 2-d and 2-f) were shared
between hematology patients and the environment. Limitations in environmental sampling do not allow for
nosocomial sources of infection to be ruled out. Future studies will focus on environmental factors that may have
influenced the prevalence of FSSC fusariosis in this hematology ward.
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Background
Over the last two decades, invasive mold infections have
become increasingly common among severely ill hospital
patients worldwide [1,2]. Fusariosis may manifest as
superficial or skin, nail and eye infections in healthy per-
sons, whereas severely immunocompromised patients
can develop invasive disease [2-5]. Invasive fusariosis
(IF) is a devastating fungal infection with high mortality
rates in patients with hematological malignancies and in
hematopoietic stem cell transplant recipients [3].
Since 2005, an increase in cases of fusariosis was
observed in a hospital in Rio de Janeiro, Brazil, both
among immunosuppressed patients in the bone marrow
transplant unit (BMTU) and also among persons with
superficial infections who were treated at the local derma-
tology clinic. In 2007, the number of cases of fusariosis in
the BMTU above the expected epidemiologic baseline was
recorded. Periodic environmental sampling in the hospital,
focused on water and water-related sources within the
BMTU, commenced in 2005 and was continued until
2009, in an attempt to identify possible environmental
reservoirs of infection. Beginning in 2006, Fusarium iso-
lates from hospital patients, hospital environmental sam-
ples, and dermatology clinic patients were archived for
further molecular analysis. Here we report the results of
comparative sequence typing performed on these archived
isolates to assess the ecology of the hospital environment,
determine the molecular genetic relatedness between
patient and environmental samples, and to estimate the
degree to which environmental Fusarium could be a reser-
voir for infection within the hospital.
Methods
Sampling and isolates
This study was conducted in the University Hospital, Federal
University of Rio de Janeiro, Brazil. The University Hospital
is a 13-floor tertiary care teaching hospital with ~480
beds. The BMTU is an isolated 18-bed ward located on
the eighth floor of the building. Rooms in the BMTU are
under positive pressure air flow, and 8 beds have high-
efficiency particulate air (HEPA) filters. Sporadic cases of
IF had been diagnosed in the BMTU at a rate of 1.47 cases
per 1000 admissions between 2000 and 2006. In 2007,
there was a sharp increase in the rate of fusariosis, reach-
ing 16.78 cases per 1000 BMTU admissions. During this
period, there was a concurrent increase of superficial
fusariosis in outpatients seen at the dermatology clinic on
the hospital’s second floor.
Fifty-five Fusarium isolates were recovered from 18 he-
matology patients (38 isolates from sterile site samples and
17 from non-sterile sites) in the BMTU as a part of standard
medical care between December 2005 and September 2009.
Forty-three Fusarium isolates were collected from skin and
nail cultures of superficial lesions (onychomycosis and
intertrigus) of 40 dermatology outpatients between June
2007 and October 2009 as part of standard medical care.
After collection, all patient isolates were plated on Sabouraud
dextrose agar (SDA), Mycosel, brain/heart infusion (BHI),
and yeast extract agars and incubated at 25°C.
Hospital environmental sampling was performed peri-
odically in the BMTU between June 2005 and Aug 2006
as part of an environmental surveillance program focused
on air, water, and water-related surfaces. In September
2006 - October 2007, environmental sampling was per-
formed in rooms of infected patients, with an emphasis
on bathroom surfaces (shower heads, drains, and tile
grout and sink surfaces and drains). Common areas of the
BMTU were also swabbed as potential point sources of
fungal contamination. Thereafter, routine environmental
surveillance of the BMTU continued through July 2009.
Environmental sampling of the outpatient dermatology
clinic was not performed.
Surfaces were sampled using Culturette swabs (Becton
Dickinson, Franklin Lakes, NJ, USA), inoculated onto SDA
plates containing 50 mg/L chloramphenicol (SDA+C), and
incubated at 25°C. Water (100 ml) was collected in sterile
glass bottles and was filtered through 0.45 μm membranes
(Millipore, Billerica, MA) which were placed on SAB plates
and incubated at 25°C. Air was sampled from patient
rooms in November 2006, August 2007, and July 2009
using a six-stage Anderson bioaerosol sampler (Anderson
Instruments, Atlanta GA) with air impacting on an SDA
plate for 30 min, for a total volume of 849 L per sample.
Control air samples were also collected from other areas of
the hospital, including the intensive care unit (2005, 2007
and 2009), pediatrics unit (2007) and the nephrology dialy-
sis unit (2007).
Fusarium were isolated from 68 samples, ranging in
time of collection from June 2005 to October 2009.
Provisional identification of hematology patient Fusarium
isolates were obtained in order to decide if more dramatic
measures should be implemented in the BMTU. This
identification was based on the micromorphology that is
typical of this genus [6].
Molecular identification and subtyping
All available Fusarium isolates collected from patients and
the environment were sent to the Centers for Diseases
Control and Prevention, Atlanta, GA, USA for molecular
identification. At the CDC, isolates were sub-cultured on
SDA+C with 50 mg/ml gentamycin agar, and incubated at
30°C for approximately 72 hours. Genomic DNA was
extracted using the Qiagen DNeasy tissue kit (Qiagen,
Valencia, CA) with slight modifications to the manufac-
turer’s instructions. Briefly, small sections of sub-cultured
Fusarium (1 cm2) were cut from mycelial mats and placed
in 5 ml polypropylene tubes containing 900 μl Qiagen
ATL buffer and 60 U proteinase K. The mycelia in each
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tube were homogenized using the Omni TH Mixer (Omni
Intl., Kennesaw, GA) at slow speed for 30 s and then high
speed for 30 s, using a clean probe between each isolate.
Homogenates were capped and incubated at 55°C for 1 h
with frequent vortexing and then cooled to RT. RNase A
(Sigma-Aldrich Corp., St. Louis, MO) was then added to a
final concentration of 1 mg/ml and incubated for 5 min at
RT, followed by the addition of 900 μl Qiagen buffer AL
and vortexing. Homogenates were incubated at 70°C for
10 min, then transferred to 1.7 ml microcentrifuge tubes
and centrifuged at 15,000 X g for 10 min. Clear superna-
tants (1 ml each) were transferred to clean microcentri-
fuge tubes and 500 μl ethanol (Sigma-Aldrich Corp.) was
added. The suspensions were vortexed and transferred to
Qiagen DNeasy columns, and manufacturer’s instructions
were followed throughout the remainder of the procedure.
A region of the translation elongation factor-1α (EF-1α)
gene was used to resolve all Fusarium isolates to the spe-
cies complex level [7] [Genbank: HM852032-HM852059].
Multi-locus sequence typing (MLST) was performed on
selected isolates. The EF-1α and two additional genetic
loci, the internal transcribed spacer (ITS) including D1/D2
and large nuclear subunit (LSU) rRNA regions (rRNA) and
a portion of the RNA polymerase II subunit (RPB2) gene,
were amplified using primers described by O’Donnell et al.
to determine species type (ST) [7] (Table 1). Additional
primers were developed for this study to sequence the 5’
(F2F and F1R) and 3’ (40-2f and 40-r) of RPB2 (Table 1).
PCR was performed in 25 μl reactions containing 0.2 μM
each forward and reverse primer, 2.5 mM MgCl2, 0.2 mM
each dNTP, and 0.625 U Taq DNA Polymerase (Roche
Carolina Inc., Florence, SC) in a buffer of 10 mM Tris
pH 8.3/50 mM KCl. Thermal cycling was performed in
MicroAmp 96-well optical reaction plates using the Gen-
eAmp PCR System 9700 (Applied Biosystems, Inc., Foster
City, CA) for forty cycles as follows: 94°C for 5 min,
10 cycles of 94°C for 30 s, 60°C for 30 s (decreasing 1°C
each cycle), 72°C for 30 s; then 30 cycles as above, but with
the annealing temperature held at, 50°C for 30 s, and a final
step of 72°C for 5 min. Amplicons were sized on 1.75%
agarose and visualized with ethidium bromide under ultra-
violet light. Amplicons were purified using Exo-SAP-IT
(USB Corp., Cleveland, OH) according to manufacturer’s
instructions, followed by sequencing with locus-specific pri-
mers using the BigDye Terminator v3.1 Cycle Sequencing
Kit (Applied Biosystems Inc.) in a 3730 DNA Analyzer
(Applied Biosystems, Inc.). Consensus sequences were ge-
nerated from raw data using Sequencher 4.9 software
(Gene Codes Corp., Ann Arbor, MI).
Comparative sequence and phylogenetic analysis
Fusarium species complexes and STs were identified
using the FUSARIUM ID database BLAST search feature
[8] [Genbank: JX156437-JX15644, Genbank: JX282603-
JX282609]. Consensus sequences were aligned using
Clustal W and cleaned within the BioEdit Sequence
Alignment Editor [9,10].
Neighbor-joining (NJ) trees were generated using
Kimura’s two-parameter model and bootstrapped using
1000 random replicates with the Phylip 3.69 software
Table 1 Primers used in multi-locus sequence typing of Fusarium isolates collected from patients and the environment
Locus Gene product (size in bp) Primer Sequence 5’-3’† PCR Sequencing




rRNA Nuclear ribosomal rRNA (986) ITS5 GGAAGTAAAAGTCGTAACAAGG x x
ITS2 GCTGCGTTCTTCATCGATGC x x
ITS3 GCATCGATGAAGAACGCAGC x x
ITS4 TCCTCCGCTTATTGATATGC x x
NL4 GGTCCGTGTTTCAAGACGG x x








† Letter designations for degenerate bases: R, A or G; S, C or G; W, A or T; Y, C or T.
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package [11]. Resultant trees were then analyzed to gener-
ate a consensus NJ tree that was annotated using FigTree
v.1.3.1 software [12]. Maximum Likelihood (MJ) and Max-
imum Parsimony (MP) algorithms were used to generate
alternate trees for comparison to the NJ tree to ensure its
validity.
Results
Molecular typing of EF-1α
A total of 166 Fusarium isolates were available for ana-
lysis. These included 98 clinical isolates (55 from 18
hematological patients, 43 from 40 dermatology patients)
and 68 isolates from environmental samples, including 14
air samples, 44 swab samples, and 10 water samples.
Comparative EF-1α sequence analysis using the FUSAR-
IUM ID database BLAST feature allowed for identification
of most study isolates to the species level, with sequence
identities ranging from 94.1% to 100% (mean = 99.9,
median = 100%) when compared with database isolates.
Frequencies of different species complexes/species iso-
lated from patients and the environment are shown in
Figure 1. Isolates from BMTU patients and dermatology
patients showed a similar distribution. The majority of iso-
lates (68%, 113/166) were identified as Fusarium solani
species complex (FSSC). Among clinical isolates, FSSC
species 2 (FSSC 2) predominated, and comprised 69%
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Figure 1 Molecular typing of Fusarium isolates (n = 168) collected from patients and the environment. Molecular typing to species
complexes and species was accomplished by amplification and genetic sequencing of the translation elongation factor 1α (EF-1α) gene. Identities of
study isolates were resolved by comparison of EF-1α molecular sequences to sequences of known Fusarium species archived in a in a curated
database, FUSARIUM ID [8]. FSSC: Fusarium solani species complex; FOSC: Fusarium oxysporum species complex; FIESC: Fusarium incarnatum-equiseti
species complex; GFSC: Gibberella fujikuroi species complex.
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Table 2 Speciation of clinical and environmental Fusarium isolates collected in a Brazilain hospital
Species ID (EF-1α Identity match%) Isolate number Collection date Sample type Isolate source
FSSC† (99.3) B8586 12/10/2005 Clinical HP01, blood
FSSC† (100) B8659 10/16/2007 Clinical DP33, skin scraping
FSSC† (99.1) B8684 7/13/2009 Clinical DP58, nail scraping
FSSC† (99.6) B8685 7/31/2009 Clinical DP60, skin scraping
FSSC 1-a B8648 7/16/2007 Clinical DP26, nail scraping
FSSC 1-a B8593 7/19/2006 Clinical HP03, lesion swab
FSSC 1-a B8710 7/31/2007 Environmental BR06, shower swab
FSSC 1-a B8711 7/31/2007 Environmental BR06, shower swab
FSSC 1-a B8712 7/31/2007 Environmental BR06, wall swab
FSSC 1-a B8714 7/31/2007 Environmental BR06, wall swab
FSSC 1-a B8715 7/31/2007 Environmental BR06, wall swab
FSSC 1-a B8716 7/31/2007 Environmental BR06, wall swab
FSSC 1-a B8720 8/14/2007 Environmental BR07, shower swab
FSSC 1-a B8721 8/14/2007 Environmental BR07, shower swab
FSSC 1-a B8690 9/21/2006 Environmental BR10, wall swab
FSSC 1-a B8694 10/5/2006 Environmental BR11, floor swab
FSSC 1-a B8741 10/25/2007 Environmental BR12, shower swab
FSSC 1-a B8696 11/1/2006 Environmental BR03, air
FSSC 1-b B8589 4/17/2006 Clinical HP02, blood
FSSC 1-b B8590 4/17/2006 Clinical HP02, blood
FSSC 1-b B8591 4/20/2006 Clinical HP02, skin biopsy
FSSC 1-b B8700 11/1/2006 Environmental BR03, floor swab
FSSC 1-b B8717 7/31/2007 Environmental BR06, wall swab
FSSC 1-b B8728 8/31/2007 Environmental BR03, sink swab
FSSC 1-b B8744 10/26/2007 Environmental BR01, water
FSSC 1-b B8745 10/26/2007 Environmental BR01, water
FSSC 1-b B8662 10/31/2007 Clinical DP36, nail scraping
FSSC 1-b B8681 5/20/2009 Clinical DP55, skin scraping
FSSC 1-b B8757 7/6/2009 Environmental BR03, shower swab
FSSC 1-b B8760 7/6/2009 Environmental BR03, air
FSSC 1-b B8637 7/28/2009 Clinical HP17, biopsy
FSSC 1-b B8638 9/4/2009 Clinical HP18, blood
FSSC 1-b B8639 9/4/2009 Clinical HP18, blood
FSSC 1-b B8640 9/4/2009 Clinical HP18, blood
FSSC 2-d B8592 7/12/2006 Clinical HP03, blood
FSSC 2-d B8697 11/1/2006 Environmental BR03, air
FSSC 2-d B8601 4/10/2007 Clinical HP07, skin biopsy
FSSC 2-d B8602 4/10/2007 Clinical HP07, vesicle
FSSC 2-d B8643 6/14/2007 Clinical DP21, nail scraping
FSSC 2-d B8603 6/18/2007 Clinical HP08, blood
FSSC 2-d B8604 6/18/2007 Clinical HP08, blood
FSSC 2-d B8605 6/18/2007 Clinical HP08, blood
FSSC 2-d B8606 6/18/2007 Clinical HP08, skin biopsy
FSSC 2-d B8607 6/19/2007 Clinical HP08, skin swab
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Table 2 Speciation of clinical and environmental Fusarium isolates collected in a Brazilain hospital (Continued)
FSSC 2-d B8608 6/21/2007 Clinical HP08, sputum
FSSC 2-d B8609 7/4/2007 Clinical HP09, skin biopsy
FSSC 2-d B8683 7/10/2009 Clinical DP57, skin scraping
FSSC 2-d B8610 7/17/2007 Clinical HP09, blood
FSSC 2-d B8611 7/17/2007 Clinical HP09, blood
FSSC 2-d B8612 7/17/2007 Clinical HP09, blood
FSSC 2-d B8613 7/4/2007 Clinical HP09, skin swab
FSSC 2-d B8616 7/26/2007 Clinical HP10, skin scraping
FSSC 2-d B8617 7/26/2007 Clinical HP10, skin scraping
FSSC 2-d B8625 8/2/2007 Clinical HP11, nail scraping
FSSC 2-d B8626 8/7/2007 Clinical HP11, lesion swab
FSSC 2-d B8649 8/10/2007 Clinical DP22, nail scraping
FSSC 2-d B8650 8/17/2007 Clinical DP27, skin scraping
FSSC 2-d B8655 9/21/2007 Clinical DP32, skin scraping
FSSC 2-d B8661 10/31/2007 Clinical DP35, skin scraping
FSSC 2-d B8749 10/31/2007 Environmental BR07, water
FSSC 2-d B8750 10/31/2007 Environmental BR07, water
FSSC 2-d B8663 1/11/2008 Clinical DP37, nail scraping
FSSC 2-d B8668 4/8/2008 Clinical DP42, nail scraping
FSSC 2-d B8669 4/24/2008 Clinical DP43, skin scraping
FSSC 2-d B8673 9/26/2008 Clinical DP47, nail scraping
FSSC 2-d B8675 10/16/2008 Clinical DP49, nail scraping
FSSC 2-d B8631 12/1/2008 Clinical HP14, lesion aspirate
FSSC 2-d B8632 12/2/2008 Clinical HP14, skin biopsy
FSSC 2-d B8679 2/20/2009 Clinical DP53, nail scraping
FSSC 2-f B8587 12/14/2005 Clinical HP01, blood
FSSC 2-f B8588 12/14/2005 Clinical HP01, blood
FSSC 2-f B8692 9/21/2006 Environmental BR10, floor swab
FSSC 2-f B8596 12/26/2006 Clinical HP04, lesion ulcer
FSSC 2-f B8597 2/4/2007 Clinical HP05, blood
FSSC 2-f B8598 2/4/2007 Clinical HP05, blood
FSSC 2-f B8599 2/5/2007 Clinical HP05, skin biopsy
FSSC 2-f B8600 3/12/2007 Clinical HP06, nail scraping
FSSC 2-f B8644 6/18/2007 Clinical DP22, nail scraping
FSSC 2-f B8645 6/18/2007 Clinical DP23, skin scraping
FSSC 2-f B8615 7/26/2007 Clinical HP10, skin swab
FSSC 2-f B8651 9/6/2007 Clinical DP28, nail scraping
FSSC 2-f B8657 10/4/2007 Clinical DP28, nail scraping
FSSC 2-f B8666 3/7/2008 Clinical DP40, nail scraping
FSSC 2-f B8671 5/14/2008 Clinical DP45, nail scraping
FSSC 2-h B8665 1/22/2008 Clinical DP39, nail scraping
FSSC 2-i B8646 6/26/2007 Clinical DP24, nail scraping
FSSC 2-i B8653 9/21/2007 Clinical DP30, nail scraping
FSSC 2-i B8670 4/28/2008 Clinical DP44, nail scraping
FSSC 2-i B8678 1/26/2009 Clinical DP52, nail scraping
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Table 2 Speciation of clinical and environmental Fusarium isolates collected in a Brazilain hospital (Continued)
FSSC 2-i B8688 10/6/2009 Clinical DP63, nail scraping
FSSC 2-i B8687 10/8/2009 Clinical DP62, skin scraping
FSSC 2-k B8642 6/5/2007 Clinical DP20, skin scraping
FSSC 2-k B8647 7/2/2007 Clinical DP25, nail scraping
FSSC 2-k B8614 7/26/2007 Clinical HP10, skin swab
FSSC 2-k B8618 9/5/2007 Clinical HP10, sinovial fluid
FSSC 2-k B8619 9/5/2007 Clinical HP10, sinovial fluid
FSSC 2-k B8620 9/10/2007 Clinical HP10, sinovial fluid
FSSC 2-k B8621 9/10/2007 Clinical HP10, sinovial fluid
FSSC 2-k B8654 9/21/2007 Clinical DP31, skin scraping
FSSC 2-k B8656 9/24/2007 Clinical DP23, nail scraping
FSSC 2-k B8622 10/8/2007 Clinical HP10, sinovial fluid
FSSC 2-k B8623 10/9/2007 Clinical HP10, sinovial fluid
FSSC 2-k B8624 10/11/2007 Clinical HP10, sinovial fluid
FSSC 2-t B8594 7/19/2006 Clinical HP03, lesion swab
FSSC 2-t B8595 7/19/2006 Clinical HP03, lesion swab
FSSC 2-t B8658 10/16/2007 Clinical DP33, skin scraping
FSSC 2-u B8652 9/17/2007 Clinical DP29, nail scraping
FSSC 2-u B8674 10/13/2008 Clinical DP48, nail scraping
FSSC 3+4 (100) B8677 12/19/2008 Clinical DP51, skin scraping
FSSC 3+4 (100) B8636 1/29/2009 Clinical HP16, corneal ulcer swab
FSSC 5 (99.5) B8676 10/17/2008 Clinical DP50, nail scraping
FSSC 7 (99.7) B8634 1/5/2008 Clinical HP15, blood
FSSC 7 (99.7) B8635 1/5/2008 Clinical HP15, blood
FOSC† (100) B8698 11/1/2006 Environmental BR03, shower swab
FOSC† (100) B8660 10/26/2007 Clinical DP34, skin scraping
FOSC† (99.7) B8667 3/27/2008 Clinical DP41, nail scraping
FOSC† (100) B8672 8/18/2008 Clinical DP46, nail scraping
FOSC† (99.9) B8633 12/18/2008 Clinical HP15, skin scraping
FOSC 33 (100) B8699 11/1/2006 Environmental BR03, wall swab
FOSC 33 (100) B8701 11/1/2006 Environmental BR03, sink swab
FOSC 33 (100) B8702 11/1/2006 Environmental BR03, sink swab
FOSC 33 (100) B8691 9/21/2006 Environmental BR10, sink swab
FOSC 33 (100) B8695 10/5/2006 Environmental BR11, sink swab
FOSC 33 (100) B8713 7/31/2007 Environmental BR06, wall swab
FOSC 33 (100) B8719 8/14/2007 Environmental BR04, sink swab
FOSC 33 (100) B8722 8/15/2007 Environmental Nephrology, wall swab
FOSC 33 (100) B8723 8/27/2007 Environmental BR01, sink swab
FOSC 33 (100) B8724 8/27/2007 Environmental BR01, faucet swab
FOSC 33 (100) B8726 8/27/2007 Environmental BR02, sink swab
FOSC 33 (100) B8727 8/27/2007 Environmental BR02, water
FOSC 33 (100) B8729 8/31/2007 Environmental BR05, sink swab
FOSC 33 (100) B8730 8/31/2007 Environmental BR05, sink swab
FOSC 33 (100) B8731 10/16/2007 Environmental BR08, sink swab
FOSC 33 (100) B8732 10/16/2007 Environmental BR08, sink swab
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74% (32/43) of those collected from dermatology patients
(Figure 1). Fusarium oxysporum species complex (FOSC)
isolates were found in much greater numbers in the hos-
pital environment (50%, 34/68) than in those collected
from hematology (5%, 3/55) and dermatology (7%, 3/43)
patients. Gibberella fujikuroi (GFSC) were isolated exclu-
sively from hematology patients and Fusarium incarna-
tum-equiseti (FIESC) exclusively from environmental
sources. FSSC 1 and FSSC 2 clinical and environmental
isolates shared between 99.7 -100% EF-1α identity with
FUSARIUM ID isolates, and were chosen for MLST due
to their predominance in patients.
Multi-locus sequence typing of FSSC and phylogenetic
analysis
Species type identifications of 104 FSSC isolates (FSSC 1 = 30,
FSSC 2 = 74) by MLST and EF-1α species complex/
species identification (42 isolates) are shown in Table 2.
The cladogram in Figure 2 represents all FSSC 2 isolates
described in this study. No cladogram was prepared for
Table 2 Speciation of clinical and environmental Fusarium isolates collected in a Brazilain hospital (Continued)
FOSC 33 (100) B8733 10/19/2007 Environmental BR09, shower swab
FOSC 33 (100) B8734 10/19/2007 Environmental BR09, shower swab
FOSC 33 (100) B8735 10/19/2007 Environmental BR09, shower swab
FOSC 33 (100) B8736 10/19/2007 Environmental BR09, wall swab
FOSC 33 (100) B8737 10/19/2007 Environmental BR09, sink swab
FOSC 33 (100) B8739 10/23/2007 Environmental BR10, sink swab
FOSC 33 (100) B8740 10/23/2007 Environmental BR11, wall swab
FOSC 33 (100) B8629 10/24/2008 Clinical HP13, blood
FOSC 33 (100) B8742 10/25/2007 Environmental BR12, sink swab
FOSC 33 (100) B8743 10/25/2007 Environmental BR12, shower swab
FOSC 33 (100) B8746 10/26/2007 Environmental BR01, water
FOSC 33 (100) B8747 10/26/2007 Environmental BR02, water
FOSC 33 (100) B8748 10/26/2007 Environmental BR02, water
FOSC 33 (100) B8630 10/30/2008 Clinical HP13, catheter tip
FOSC 33 (100) B8752 10/31/2007 Environmental BR07, water
FOSC 33 (100) B8756 7/6/2009 Environmental BR06, sink swab
FOSC 33 (100) B8758 7/6/2009 Environmental BR03, sink swab
FOSC 33 (100) B8762 7/27/2009 Environmental BR06, sink swab
FOSC 183 (100) B8751 10/31/2007 Environmental BR02, water
FIESC† (98) B8709 8/7/2007 Environmental BR04, air
FIESC 15 (100) B8689 6/30/2005 Environmental BR06, air
FIESC 15 (100) B8703 1/29/2007 Environmental ICU, air (control)
FIESC 15 (100) B8704 1/29/2007 Environmental ICU, air (control)
FIESC 15 (100) B8705 6/13/2007 Environmental ICU, air (control)
FIESC 15 (99.5) B8706 6/13/2007 Environmental ICU, air (control)
FIESC 15 (100) B8753 4/30/2009 Environmental ICU, air (control)
FIESC 15 (100) B8755 4/30/2009 Environmental ICU, air (control)
FIESC 17 (100) B8708 6/18/2007 Environmental Pediatrics, air (control)
FIESC 20 (100) B8707 6/18/2007 Environmental Pediatrics, air (control)
FIESC 20 (100) B8759 7/6/2009 Environmental BR03, air
GFSC (94.1) B8627 4/18/2008 Clinical HP12, blood
GFSC (94.1) B8628 4/18/2008 Clinical HP12, blood
† Species identity not determined due to multiple genetic matches.
Note: Each isolate was given a unique isolate number. Isolate sources have designations as follows: BR (bathroom), HP (hematology patient), DP (dermatology
patient), followed by a source number. In many cases, more than one isolate was collected from the same source.
Abbreviations: FSSC, Fusarium solani species complex;FOSC, Fusarium oxysporum species complex; FIESC, Fusarium incarnatum equiseti species complex; GFSC,
Gibberella fujikuroi species complex.
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Figure 2 Neighbor-joining phylogeny of Fusarium solani species complex (FSSC) species 2 isolates (n = 74). Bootstrap values were 100%
between individual taxa (1000 iterations, data not shown). Included are previously described FSSC species 2 voucher sequences (labeled FSSC 2-d,
FSSC 2-f, FSSC 2-h, FSSC 2-I, FSSC 2-k, and FSSC 2-u) that were retrieved from the FUSARIUM ID database [8].
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FSSC 1-a and 1-b isolates, since these STs differ by only
one base pair.
FSSC 2-d and FSSC 2-f were the most common STs iso-
lated from patients (Figure 2). FSSC 2-d was collected
from seven patients in the BTMU (20 isolates) and 12
dermatology outpatients, while FSSC 2-f was isolated from
five BTMU patients (8 isolates) and five dermatology out-
patients (6 isolates). FSSC 2 isolates were rarely found in
the environment (n = 4); two FSSC 2-d isolates were col-
lected from the same water source (BR07) on the same
day, one FSSC 2-d was isolated from an air sample
(BR03), and FSSC 2-f was collected from a floor swab of
BR10. None of the environmental FSSC 2 isolates were
collected within the same month as those collected from
patients in the BMTU (Table 2).
FSSC 2-k (1 patient, 8 isolates) and FSSC 2-t (1 pa-
tient, 2 isolates) were the other STs identified by MLST
in the BMTU, but none were collected in the environment
(Figure 2). Other Fusarium isolated in hematology patients
were provisionally identified by EF-1α sequence compari-
son and each was found in one BMTU patient. These were
FSSC 3+4 (HP16, corneal swab), FSSC 7 (HP15, blood),
FOSC 33 (HP13, blood and catheter tip), GFSC (HP12,
blood), and unspeciated FSSC (HP01, blood) and FOSC
(HP15, skin) (Table 2).
Among environmental isolates, FOSC 33 comprised al-
most half of all samples collected, and was isolated 32
times between September 2006 and July 2009, with the
majority (24) sampled between August and October 2007.
This species was found in water-related surface swabs of
all 12 BMTU bathrooms, a nephrology wall swab (control),
and water of two bathrooms (BR02, BR07). FOSC 33 was
also isolated from blood and a catheter tip of a patient
(HP13) in October 2008, but none were collected from the
environment that month (Table 2).
Forty-three bathroom swabs were performed between
September 2006 and July 2009, and 6 different Fusarium
species/STs were recovered; FOSC (unknown species) and
FOSC 33, FSSC 1-a, 1-b, 2-d, and 2-f. Water samples posi-
tive for Fusarium (n = 10) were collected in four bath-
rooms (BR01, 02, 03, 07) and yielded four STs; FOSC 183,
FOSC 33, FSSC 1-b and FSSC 2-d. Only BR01 and BR07
were positive for FSSC (1-b, and 2-d, respectively), and
water in these rooms also yielded FOSC STs. FIESC was
collected from air in three bathrooms (BR03, BR04, BR06)
and from 8 control samples. Three other STs were found
in air, FSSC 1-a, 1-b, and 2-d, and all were collected from
BR03.
Discussion
Given the severe morbidity and mortality from Fusarium
infections, it is important to understand the sources of
these organisms and determine the extent to which fusaria
may be transmitted in the hospital. One such study by
Anaissie in 2001 implicated hospital water systems
(drains, faucet aerators, shower heads) as potential reser-
voirs for Fusarium, and suggested that these fungi can be
transmitted through the water system due to their persist-
ence in plumbing systems [13]. In the United States, Short
et al. recently confirmed these findings by performing an
extensive MLST study of fusaria recovered from plumbing
drains in the United States [14]. They found that the 6
most common sequence types in drains (FSSC 1-a, 1-b,
2-d, 2-k, FOSC 33 and Fusarium dimerum) were also the
six most commonly associated with human infection. Our
study bolsters the findings of Short et al. with regard to
common Fusarium STs isolated from water-related
sources, since we also found that FOSC 33 was the most
common ST isolated in drains, faucets, and tiles of
showers and sinks in the hospital. Unlike Short et al., we
found FSSC 1-a and FSSC 1-b to be more commonly
found in these sources, as opposed to FSSC 2-d. Our study
differs in two ways, however, since environmental sam-
pling was conducted in Brazil, and only exterior plumbing
surfaces were sampled.
Several studies have shown that MLST of three loci
(EF-1α, rRNA and RPB2) have the highest discriminatory
power in delineating FSSC using comparative sequence
analyses [7,15,16]. We used this three-locus method and
found that subtypes of most BTMU inpatient clinical iso-
lates belonged to FSSC species 2 (69%, 38/55), and were
primarily 2-d (recovered from 36% of patients) and 2-f
(recovered from 18% of patients). In contrast, FSSC isolates
comprised 36% of the environmental samples and were
shown to be predominantly species type 1-a (18%) and 1-b
(13%), while only four environmental samples were FSSC 2.
The remaining environmental samples were predominantly
FOSC from swabs and water (50% of environmental
samples) and FIESC from air (79% of air samples). We did
not find any FIESC clinical isolates, although we did find
two FOSC clinical cases. Our data suggest that most of the
clinical cases of fusariosis in this immunosuppressed popu-
lation could not be traced to a specific water-related envi-
ronmental source in the hospital ward. However, because
we found a small number of species type-level matches
between clinical and environmental isolates, we believe that
in this institution, environmental water-related sources and
even air must be considered as possible reservoirs for pa-
tient infection.
In this study, we were unable to find any temporal associ-
ation between BMTU patient fusarial infections and con-
taminated water-related sources in the BMTU environment.
We explored the epidemiology of community acquisition by
studying a population of dermatology outpatients diagnosed
with skin or nail fusariosis who were seen at the hospital
during the same period. The spectrum of Fusarium STs
recovered from these patients largely mirrored those
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recovered from BMTU inpatients (Figure 1). A study by
Raad et al. used RAPD subtyping to demonstrate that Fu-
sarium DNA collected from 10 infected patients did not
match DNA from 15 environmental isolates collected from
shower head water, sink water, and drains in their institution
[17]. Our study was far more extensive and yielded similar
results.
Both Anassie and Short [13,14] have implicated water
systems as reservoirs of fusariosis, but in our study we
found only FSSC 1 to be common in both hematology
patients and the environment. It is possible that Fusarium
patient subtypes could have been missed in the hospital
environment because of limitations in the environmental
investigation. Environmental sampling was sporadic and
was limited in scope, so potential sources of contamination
may have been missed. Few samples were collected from
air in the BMTU, and surfaces of other fomites in the pa-
tient rooms were not sampled; rather focus was placed on
the patient bathrooms, pursuing the hypothesis that water-
related sources were Fusarium reservoirs. Additionally, the
methods used for environmental sample collection may
not have been optimal for Fusarium recovery.
The diversity of Fusarium STs among dermatology pa-
tients with superficial infections was greater than that of
BMTU patients, and the distribution of STs was highly
similar between these patient populations. We found that a
single species, FSSC 2-d, predominated in both inpatient
hematology and outpatient dermatology samples. Certainly,
our combined patient data suggest that FSSC species re-
main a cause of superficial colonization, and under appro-
priate circumstances of immunosuppression, could cause
disease in an IHC patient population. The increase in
fusariosis in this and other hospitals (personal communica-
tion, Marcio Nucci) suggests that there may be a significant
increase in circulating Fusarium conidia in this geogra-
phical region. Our findings raise important questions for
future research, including a search for the environmental
reservoirs of Fusarium spp., an explanation for this surge
of environmental Fusarium, and the potential implications
of these findings in infection control measures.
Conclusions
We isolated similar Fusarium species in this hospital and
outpatient setting. The limited environmental investigation
coupled with molecular analysis did not show a definitive
link to clinical isolates causing infection. Future studies are
needed in order to identify reservoirs of Fusarium in the
community, as well as preventive measures for patients at
high risk for IF.
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